Editorial
Published on 15 Jul 2024
Editorial: Targeting mitochondrial dysfunction for the diagnosis and treatment of Alzheimer’s and cognitive-related diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1455646
Type at least 3 characters
23,226 articles
Articles
Original Research
Published on 15 Jul 2024
Detection of muscular system adverse reaction signals in sacubitril/valsartan treatment combined with statins
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1393616
Original Research
Published on 15 Jul 2024
Superior cuproptotic efficacy of diethyldithiocarbamate-Cu4O3 nanoparticles over diethyldithiocarbamate-Cu2O nanoparticles in metastatic hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1388038
Review
Published on 15 Jul 2024
Advancing vaccine development against Opisthorchis viverrini: A synergistic integration of omics technologies and advanced computational tools
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1410453
Original Research
Published on 15 Jul 2024
Association between amoxicillin administration and outcomes in critically ill patients with acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1409654
Systematic Review
Published on 15 Jul 2024
Effectiveness of traditional herbal Kampo medicine Goreisan on chronic subdural hematoma recurrence: a meta-analysis
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1412190
Clinical Trial
Published on 15 Jul 2024
A phase 1, randomized, double-blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of SHR-1905, a long-acting anti-thymic stromal lymphopoietin antibody, in healthy subjects
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1400696
- 114 views
Original Research
Published on 15 Jul 2024
Effects of Alhagi maurorum Medik polysaccharide derived from different regions on the intestinal immune functions of lambs
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1422461
Original Research
Accepted on 12 Jul 2024
Real-World Study of Adverse Events Associated with Gepant Use in Migraine Treatment Based on the VigiAccess and U.S. Food and Drug Administration's Adverse Event Reporting System Databases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431562
Original Research
Accepted on 12 Jul 2024
Gestodene, a Novel Positive Allosteric Modulator of PAR1, Enhances PAR1-mediated Human Platelet Aggregation
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430548
Original Research
Accepted on 12 Jul 2024
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for sunitinib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407709
Original Research
Accepted on 12 Jul 2024
Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1398953
Editorial
Accepted on 12 Jul 2024
Editorial: The Culprit Behind Some Diseases: Overexpression/Hyperactivity of G6PD
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1459741
Original Research
Accepted on 12 Jul 2024
Effect of lateral septum vasopressin administration on reward system neurochemistry and amphetamine-induced addictive-like behaviors in female rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411927
Review
Accepted on 12 Jul 2024
Anti-inflammatory properties of polysaccharides from edible fungi on health-promotion: a review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1447677
Review
Accepted on 12 Jul 2024
Anti-TNFa in inflammatory bowel disease: from originators to biosimilars
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1424606